5441842025-04-012025-06-305441842025-06-305441842025-04-012025-06-30in-capmkt:OtherExpenses1Member5441842025-04-012025-06-30in-capmkt:ReportableSegments1Member5441842025-04-012025-06-30in-capmkt:ReportableSegments2Member5441842025-04-012025-06-30in-capmkt:ReportableSegments3Member5441842025-04-012025-06-30in-capmkt:ReportableSegments1Member5441842025-04-012025-06-30in-capmkt:ReportableSegments2Member5441842025-04-012025-06-30in-capmkt:ReportableSegments3Member5441842025-04-012025-06-30in-capmkt:ReportableSegments1Member5441842025-06-30in-capmkt:ReportableSegments1Member5441842025-04-012025-06-30in-capmkt:ReportableSegments2Member5441842025-06-30in-capmkt:ReportableSegments2Member5441842025-04-012025-06-30in-capmkt:ReportableSegments3Member5441842025-06-30in-capmkt:ReportableSegments3Member5441842025-04-012025-06-30in-capmkt:ReportableSegments1Member5441842025-06-30in-capmkt:ReportableSegments1Member5441842025-04-012025-06-30in-capmkt:ReportableSegments2Member5441842025-06-30in-capmkt:ReportableSegments2Member5441842025-04-012025-06-30in-capmkt:ReportableSegments3Member5441842025-06-30in-capmkt:ReportableSegments3Member5441842025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15441842025-04-012025-06-30AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares544184BOROSCINOTLISTEDINE02L001032BOROSIL SCIENTIFIC LIMITEDMain BoardEquity2025-04-012026-03-312025-08-112025-08-11INRLakhsQuarterlyFirst quarterMulti segment2025-08-1112:00:002025-08-1113:00:00Declaration of unmodified opinionfalsefalseNot applicable2025-04-012025-06-30UnauditedStandalone8900950003060400092069900030655300014870000-1251200015653000018190004466800033601500084794300072756000-661310006625000020490002049000045760000000457600018500047610008894600010.050.05000.050.05000Notes on Unaudited Standalone Financial Results for the quarter ended 30th June, 2025: <BR> <BR> 1. The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on 11th August, 2025. The Statutory Auditors of the Company have carried out a Limited Review of the above results. <BR> <BR> 2. Pursuant to exercise of the options issued under “Borosil Scientific Limited - Special Purpose Employee Stock Option Plan 2023”, the Company has made allotment of 12,625 Equity Shares of the face value of Re. 1/- each for the quarter ended 30th June, 2025, which has resulted into increase of paid up Equity Share Capital by Rs. 0.13 lakhs and Securities Premium by Rs. 13.80 lakhs <BR> <BR> 3. As informed earlier, the Company had introduced a Voluntary Retirement Scheme (VRS) for the eligible workers at its plant situated at Village Ambad, Nashik, Maharashtra . During the quarter, the Company entered into a Memorandum of Settlement, with the Bhartiya Kamgar Sena (BKS), outlining the terms of final settlement under VRS. BKS is a trade union registered under Trade Union’s Act, 1926, representing the said eligible workers. The above settlement resulted total expenditure of Rs. 661.31 lakhs (including professional fees related to the above) and shown as an exceptional item in the above results. <BR> <BR> 4. The figures for the corresponding previous period/year have been rearranged/ regrouped, wherever necessary, to make them comparable. The figures for the quarter ended 31st March, 2025 is the balancing figures between the audited figures of the full financial year and the published year to date figures upto the third quarter of the respective financial year. <BR> <BR> <BR> For Borosil Scientific Limited <BR> (Formerly Known as Klass Pack Limited) <BR> <BR> <BR> <BR> <BR> Place: Mumbai Vinayak Patankar <BR> Date :11st August, 2025 Whole-time Director and CEO <BR> (DIN 07534225) <BR> Other Expenses336015000Scientific – Laboratory Glass & equipment and Process System562581000Glassware321312000Others62020008900950000890095000Scientific – Laboratory Glass & equipment and Process System130642000Glassware-24026000Others239200010900800018190001005640006625000Scientific – Laboratory Glass & equipment and Process System1397634000Glassware1080516000Others19423000249757300024194540004917027000Scientific – Laboratory Glass & equipment and Process System332128000Glassware205066000Others1703000538897000163608000702505000Note <BR> <BR> As per Indian Accounting Standard 108 on Operating Segment Ind AS 108 the Company has reported Segment information as described below <BR> <BR> <BR> Scientific <BR> Laboratory Glass and equipment and Process System <BR> Comprising of items used in laboratories production floor and research and development <BR> <BR> Glassware <BR> Pharmaceutical primary packaging and domestic glassware items <BR> <BR> Others <BR> Comprising of Filter Paper etc <BR> <BR> Unallocated <BR> Consists of income expenses assets and liabilities which can not be directly identified to any of the above segments <BR> Re-measurement gains / (losses) on defined benefit plans247000247000620000185000UnauditedtrueM/s. Chaturvedi & Shah LLPtrue2026-06-30